Literature DB >> 22414236

Negative life events and substance use moderate cognitive behavioral adolescent depression prevention intervention.

Jeff M Gau1, Eric Stice, Paul Rohde, John R Seeley.   

Abstract

Investigate factors that amplify or mitigate the effects of an indicated cognitive behavioral (CB) depression prevention program for adolescents with elevated depressive symptoms. Using data from a randomized trial (Registration No. NCT00183417; n = 173) in which adolescents (M age=15.5, SD=1.2) were assigned to a brief cognitive behavioral prevention program or an educational brochure control condition, we tested whether elevated motivation to reduce depression and initial depressive symptom severity amplified intervention effects and whether negative life events, social support deficits, and substance use attenuated intervention effects. Hierarchical linear modeling (HLM) indicated differential intervention effects for two of the five examined variables: negative life events and substance use. For adolescents at low and medium levels of substance use or negative life events, the CB intervention produced declines in depressive symptoms relative to controls. However, at high levels of substance use or negative life events, the CB intervention did not significantly reduce depressive symptoms in comparison to controls. Results imply that high-risk adolescents with either high rates of major life stress or initial substance use may require specialized depression prevention efforts.

Entities:  

Mesh:

Year:  2012        PMID: 22414236      PMCID: PMC3577375          DOI: 10.1080/16506073.2011.649781

Source DB:  PubMed          Journal:  Cogn Behav Ther        ISSN: 1650-6073


  27 in total

1.  r equivalent: A simple effect size indicator.

Authors:  Robert Rosenthal; Donald B Rubin
Journal:  Psychol Methods       Date:  2003-12

2.  Factors associated with dropout from group psychotherapy with depressed adolescents.

Authors:  M Gilbert; S Fine; G Haley
Journal:  Can J Psychiatry       Date:  1994-08       Impact factor: 4.356

Review 3.  Identifying and developing empirically supported child and adolescent treatments.

Authors:  A E Kazdin; J R Weisz
Journal:  J Consult Clin Psychol       Date:  1998-02

4.  Participation in community residential treatment and substance abuse patients' outcomes at discharge.

Authors:  R H Moos; M J King
Journal:  J Subst Abuse Treat       Date:  1997 Jan-Feb

5.  Problems of internal consistency and scaling in life event schedules.

Authors:  P J Cleary
Journal:  J Psychosom Res       Date:  1981       Impact factor: 3.006

6.  The assessment of life change stress: a comparative and methodological inquiry.

Authors:  M W Hurst; C D Jenkins; R M Rose
Journal:  Psychosom Med       Date:  1978-03       Impact factor: 4.312

7.  Which depressed patients respond to cognitive-behavioral treatment?

Authors:  D Jayson; A Wood; L Kroll; J Fraser; R Harrington
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-01       Impact factor: 8.829

8.  Prevention of depressive symptoms in school children.

Authors:  L H Jaycox; K J Reivich; J Gillham; M E Seligman
Journal:  Behav Res Ther       Date:  1994-11

9.  Adolescent psychopathology: II. Psychosocial risk factors for depression.

Authors:  P M Lewinsohn; R E Roberts; J R Seeley; P Rohde; I H Gotlib; H Hops
Journal:  J Abnorm Psychol       Date:  1994-05

10.  Stress burden and the lifetime incidence of psychiatric disorder in young adults: racial and ethnic contrasts.

Authors:  R Jay Turner; Donald A Lloyd
Journal:  Arch Gen Psychiatry       Date:  2004-05
View more
  12 in total

1.  Moderators of the effects of indicated group and bibliotherapy cognitive behavioral depression prevention programs on adolescents' depressive symptoms and depressive disorder onset.

Authors:  Sina Müller; Paul Rohde; Jeff M Gau; Eric Stice
Journal:  Behav Res Ther       Date:  2015-10-09

2.  Moderators of two indicated cognitive-behavioral depression prevention approaches for adolescents in a school-based effectiveness trial.

Authors:  Frédéric N Brière; Paul Rohde; Heather Shaw; Eric Stice
Journal:  Behav Res Ther       Date:  2013-12-27

Review 3.  Evidence Base Update of Psychosocial Treatments for Child and Adolescent Depression.

Authors:  V Robin Weersing; Megan Jeffreys; Minh-Chau T Do; Karen T G Schwartz; Carl Bolano
Journal:  J Clin Child Adolesc Psychol       Date:  2016-11-21

4.  Mediators and Moderators of a School-Based Cognitive-Behavioral Depression Prevention Program.

Authors:  Mylien T Duong; Brynn M Kelly; Wren L Haaland; Brandon Matsumiya; Stanley J Huey; Carolyn A McCarty
Journal:  Cognit Ther Res       Date:  2016-04-28

5.  Effects of three depression prevention interventions on risk for depressive disorder onset in the context of depression risk factors.

Authors:  Paul Rohde; Eric Stice; Jeff M Gau
Journal:  Prev Sci       Date:  2012-12

6.  Moderators of two dual eating disorder and obesity prevention programs.

Authors:  Eric Stice; Christopher D Desjardins; Heather Shaw; Paul Rohde
Journal:  Behav Res Ther       Date:  2019-04-12

7.  Indicated cognitive behavioral group depression prevention compared to bibliotherapy and brochure control: acute effects of an effectiveness trial with adolescents.

Authors:  Paul Rohde; Eric Stice; Heather Shaw; Frédéric N Brière
Journal:  J Consult Clin Psychol       Date:  2013-10-07

8.  GROUP-BASED SYMPTOM TRAJECTORIES IN INDICATED PREVENTION OF ADOLESCENT DEPRESSION.

Authors:  Frédéric N Brière; Paul Rohde; Eric Stice; Julien Morizot
Journal:  Depress Anxiety       Date:  2015-10-12       Impact factor: 6.505

9.  Major depression prevention effects for a cognitive-behavioral adolescent indicated prevention group intervention across four trials.

Authors:  Paul Rohde; Frédéric N Brière; Eric Stice
Journal:  Behav Res Ther       Date:  2017-10-31

Review 10.  Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents.

Authors:  Sarah E Hetrick; Georgina R Cox; Katrina G Witt; Julliet J Bir; Sally N Merry
Journal:  Cochrane Database Syst Rev       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.